News


All News

While laws vary from state to state as to who in a practice can legally operate a laser or light source or energy-based device, the responsibility often lies with the practice physician, according to Mathew M. Avram, M.D., J.D.

The Centers for Medicare and Medicaid Services (CMS) has granted reimbursement codes to reflectance confocal microscopy (RCM), a noninvasive tool for identifying benign lesions, which can spare patients from needing biopsies, as well as detect malignant lesions.

A recent study found that cosmetic treatments performed on presumed benign pigmented lesions later found to be lentigo maligna (LM) is not an uncommon occurrence, underscoring the need for individuals performing cosmetic procedures to be more vigilant in thoroughly investigating suspicious lesions.

Microneedling may provide a viable alternative to lasers in certain clinical situations. Dr. Mara Weinstein Velez discusses which indications have promising data behind them and where further research needs to focus.

How psoriasis arises

The research road to streamlining the model of psoriasis pathogenesis.

When it comes to treating psoriasis in non-white patients, there is a paucity of data on differences in epidemiology, clinical presentation and approaches to treatment.

The lone star tick, whose bite causes allergies to red meat, is spreading across more states, according to news reports. Reports of allergies traced to the lone star tick bites occur most frequently in the southeastern U.S., but it has spread to areas such as Long Island, N.Y.; Hanover, N.H., and Duluth, Minn.

The US Food and Drug Administration (FDA) has expanded the approval of ipilimumab (Yervoy) to include the treatment of pediatric melanoma patients 12 years and older with unresectable or metastatic disease.

The approval of abatacept (Orencia/Bristol-Myers Squibb) for psoriatic arthritis (PsA) earlier this month by the FDA offers a new treatment option for patients who are struggling to keep the disease under control.

Eric Schweiger, M.D., C.E.O., and founder of the Schweiger Dermatolo- gy Group, has been named a semifinalist for the EY Entrepreneur of the Year 2017 Award for the New York region, according to a news release.

Collaboration with specialists in other fields can improve outcomes for patients with skin cancer, and it can be personally and professionally rewarding for the dermatologist, according to one expert.